Servier, shared a post on LinkedIn:
“We’ll be attending the ESMO GI 26 Congress, a key global event in gastrointestinal oncology.
Our teams look forward to engaging with the scientific community, sharing insights, and contributing to discussions aimed at advancing research and improving patient outcomes.
Meet us at our booth – N° 2 and join our symposiums:
- July 2 | 6:15–7:15 pm (CEST) ‘Impact in Practice: How Precision Medicine and Real-World Evidence are Shaping Cholangiocarcinoma Care‘.
- July 3 | 12:45–1:45 pm (CEST) ‘From Guidelines to Clinical Practice: How to Facilitate Decision Making in Metastatic Pancreatic Cancer?’.
- July 3 | 6:15–7:15 pm (CEST) ‘Leveraging Early Tumor Shrinkage and Optimal Sequencing to Maximize Patient Outcomes in mCRC‘.
Learn more about our commitment in oncology.”
Other articles about ESMO on OncoDaily.